Literature DB >> 27074221

Concordance between bronchial hyperresponsiveness, fractional exhaled nitric oxide, and asthma control in children.

Biju Thomas1,2, Oh Moh Chay3,4, John C Allen4, Andrea Shu Xian Chiang3, Arun Pugalenthi3,4, Anne Goh3,4, Petrina Wong3, Ai Huay Teo3, Soh Gin Tan3, Oon Hoe Teoh3,4.   

Abstract

BACKGROUND: Previous studies on association between level of asthma control, markers of airway inflammation and the degree of bronchial hyperresponsiveness (BHR) have yielded conflicting results. Our aim was to determine the presence and severity of BHR and the concordance between BHR, asthma control, and fractional exhaled nitric oxide (FeNO) in children with asthma on therapy.
METHODS: In this cross-sectional observational study, children (aged 6-18 years) with asthma on British Thoracic Society (BTS) treatment steps 2 or 3, underwent comprehensive assessment of their asthma control (clinical assessment, spirometry, asthma control test [ACT], Pediatric Asthma Quality of Life Questionnaire [PAQLQ]), measurement of FeNO and BHR (using mannitol dry powder bronchial challenge test [MCT], Aridol™, Pharmaxis, Australia).
RESULTS: Fifty-seven children (63% male) were studied. Twenty-seven children were on BTS treatment step 2 and 30 were on step 3. Overall, 25 out of 57 (43.8%) children had positive MCT. Of note, 9 out of 27 (33.3%) children with clinically controlled asthma had positive MCT. Analyses of pair-wise agreement between MCT (positive or negative), FeNO (>25 or ≤25 ppb) and clinical assessment of asthma control (controlled or partially controlled/uncontrolled) showed poor agreement between these measures.
CONCLUSIONS: A substantial proportion of children with asthma have persistent BHR despite good clinical control. The concordance between clinical assessment of asthma control, BHR and FeNO was observed to be poor. Our findings raise concerns in the context of emerging evidence for the role of bronchoconstriction in inducing epithelial stress that may drive airway remodeling in asthma. Pediatr Pulmonol. 2016;51:1004-1009.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  airway hyperresponsiveness; asthma; asthma control; bronchial hyperresponsiveness; fractional exhaled nitric oxide (FeNO)

Mesh:

Substances:

Year:  2016        PMID: 27074221     DOI: 10.1002/ppul.23426

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  3 in total

1.  Prospective observational cohort study of symptom control prediction in paediatric asthma by using the Royal College of Physicians three questions.

Authors:  Glen Andrews; David K H Lo; Matthew Richardson; Andrew Wilson; Erol A Gaillard
Journal:  NPJ Prim Care Respir Med       Date:  2018-10-24       Impact factor: 2.871

Review 2.  Pediatric pulmonology year in review 2016: Part 2.

Authors:  Richard Auten; Clement Ren; Ozge Yilmaz; Terry L Noah
Journal:  Pediatr Pulmonol       Date:  2017-04-25

3.  Concordance for changes in allergic asthma domain variables after short-term corticosteroid therapy.

Authors:  Philip E Silkoff; Mark Sarno; Solomon Ssenyange; Vivek Balasubramanyam; Brian Awabdy; Ryan Leard
Journal:  BMC Pulm Med       Date:  2020-05-14       Impact factor: 3.317

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.